Visionary Horizons’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$545K Buy
4,315
+6
+0.1% +$791 0.23% 79
2026
Q1
$601K Sell
4,309
-177
-4% -$24.8K 0.3% 68
2025
Q4
$551K Sell
4,486
-80
-2% -$9.72K 0.28% 68
2025
Q3
$507K Hold
4,566
0.28% 70
2025
Q2
$506K Sell
4,566
-325
-7% -$34.6K 0.32% 64
2025
Q1
$548K Sell
4,891
-801
-14% -$82.7K 0.39% 55
2024
Q4
$526K Sell
5,692
-185
-3% -$16.7K 0.35% 56
2024
Q3
$493K Hold
5,877
0.33% 56
2024
Q2
$403K Buy
5,877
+175
+3% +$11.7K 0.3% 65
2024
Q1
$388K Hold
5,702
0.3% 62
2023
Q4
$462K Buy
+5,702
New +$444K 0.37% 50

Other funds holding GILD

Visionary Horizons's GILD Position: Q2 2026 in Review

Visionary Horizons increased its Gilead Sciences (GILD) stake by 0.14% in Q2 2026, buying an estimated $791 and bringing the position to 4,315 shares worth $545K. The position accounts for 0.23% of the portfolio, ranked #79.

Visionary Horizons first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $601K in Q1 2026. 1,031 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Visionary Horizons held 4,315 shares of Gilead Sciences worth $545K as of Q2 2026.
  • Visionary Horizons bought 6 Gilead Sciences shares in Q2 2026, an estimated $791.
  • Gilead Sciences made up 0.23% of Visionary Horizons's portfolio in Q2 2026, its #79 holding.
  • Visionary Horizons first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Visionary Horizons's Gilead Sciences position peaked at $601K in Q1 2026.
  • 1,031 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Visionary Horizons's 13F filing for Q2 2026, filed 16 Jul 2026.